| 1 |
35245520 | Enhanced in vitro tumoricidal effects of 5-Fluorouracil, thymoquinone, and active vitamin D3 triple therapy against colon cancer cells by attenuating the PI3K/AKT/mTOR pathway. | 2022 May 1 |
1 |
| 2 |
35326689 | In Vivo and In Vitro Enhanced Tumoricidal Effects of Metformin, Active Vitamin D3, and 5-Fluorouracil Triple Therapy against Colon Cancer by Modulating the PI3K/Akt/PTEN/mTOR Network. | 2022 Mar 17 |
1 |
| 3 |
35354250 | Glycolytic enzyme PFKFB3 determines bone marrow endothelial progenitor cell damage post chemotherapy and irradiation. | 2022 Mar 31 |
1 |
| 4 |
33240430 | Potentiating activities of chrysin in the therapeutic efficacy of 5-fluorouracil in gastric cancer cells. | 2021 Jan |
1 |
| 5 |
34970530 | Design, Synthesis, Chemical and Biochemical Insights Into Novel Hybrid Spirooxindole-Based p53-MDM2 Inhibitors With Potential Bcl2 Signaling Attenuation. | 2021 |
1 |
| 6 |
35096810 | Down-Regulating HAUS6 Suppresses Cell Proliferation by Activating the p53/p21 Pathway in Colorectal Cancer. | 2021 |
1 |
| 7 |
31097925 | Coelomic Fluid of Lumbricus rubellus Synergistically Enhances Cytotoxic Effect of 5-Fluorouracil through Modulation of Focal Adhesion Kinase and p21 in HT-29 Cancer Cell Line. | 2019 |
3 |
| 8 |
31366086 | Lipoic Acid Synergizes with Antineoplastic Drugs in Colorectal Cancer by Targeting p53 for Proteasomal Degradation. | 2019 Jul 30 |
1 |
| 9 |
27871087 | The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53wild type Neuroendocrine Tumor Cell Line GOT1. | 2018 |
2 |
| 10 |
29053388 | Some chemotherapeutics-treated colon cancer cells display a specific phenotype being a combination of stem-like and senescent cell features. | 2018 Jan 2 |
1 |
| 11 |
29702091 | Inhibition of MALAT1 sensitizes liver cancer cells to 5-flurouracil by regulating apoptosis through IKKα/NF-κB pathway. | 2018 Jun 18 |
1 |
| 12 |
30304835 | Cytoplasmic p21 Mediates 5-Fluorouracil Resistance by Inhibiting Pro-Apoptotic Chk2. | 2018 Oct 9 |
3 |
| 13 |
28382142 | Protein Regulator of Cytokinesis PRC1 Confers Chemoresistance and Predicts an Unfavorable Postoperative Survival of Hepatocellular Carcinoma Patients. | 2017 |
1 |
| 14 |
28816773 | Synergistic antitumor effect of 3-bromopyruvate and 5-fluorouracil against human colorectal cancer through cell cycle arrest and induction of apoptosis. | 2017 Sep |
1 |
| 15 |
26687645 | Oxymatrine synergistically enhances the inhibitory effect of 5-fluorouracil on hepatocellular carcinoma in vitro and in vivo. | 2016 Jun |
1 |
| 16 |
26774139 | Chidamide and 5-flurouracil show a synergistic antitumor effect on human colon cancer xenografts in nude mice. | 2016 |
1 |
| 17 |
26785286 | 5-Fluorouracil-Induced Apoptosis Changes in Cultured Corneal Epithelial Cells. | 2016 Apr |
1 |
| 18 |
27509880 | Combination of the histone deacetylase inhibitor depsipeptide and 5-fluorouracil upregulates major histocompatibility complex class II and p21 genes and activates caspase-3/7 in human colon cancer HCT-116 cells. | 2016 Oct |
1 |
| 19 |
24708484 | P21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancer. | 2014 Apr 4 |
2 |
| 20 |
24919507 | Vitamin D analogs combined with 5-fluorouracil in human HT-29 colon cancer treatment. | 2014 Aug |
2 |
| 21 |
23787902 | Epigenetic silencing of DACH1 induces loss of transforming growth factor-β1 antiproliferative response in human hepatocellular carcinoma. | 2013 Dec |
2 |
| 22 |
23810214 | A study of the combination of triamcinolone and 5-fluorouracil in modulating keloid fibroblasts in vitro. | 2013 Sep |
1 |
| 23 |
19621385 | Synergistic antitumor effects of FGFR2 inhibitor with 5-fluorouracil on scirrhous gastric carcinoma. | 2010 Feb 15 |
1 |
| 24 |
20633010 | Low-dose 5-fluorouracil induces cell cycle G2 arrest and apoptosis in keloid fibroblasts. | 2010 Dec |
1 |
| 25 |
18834353 | Effect of Bupleuri Radix extracts on the toxicity of 5-fluorouracil in HepG2 hepatoma cells and normal human lymphocytes. | 2008 Oct |
1 |
| 26 |
12518324 | Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: in vitro and in vivo activities and mechanisms. | 2003 Feb 15 |
1 |
| 27 |
14751837 | Chemosensitization and radiosensitization of human cancer by antisense anti-MDM2 oligonucleotides: in vitro and in vivo activities and mechanisms. | 2003 Dec |
1 |
| 28 |
11299739 | Correlation of immunohistochemical p53 labeling index with inhibition rate in chemosensitivity test in gastric and colon cancer. | 2001 Jan-Feb |
1 |
| 29 |
10785598 | Molecular downstream events and induction of thymidylate synthase in mutant and wild-type p53 colon cancer cell lines after treatment with 5-fluorouracil and the thymidylate synthase inhibitor raltitrexed. | 2000 May |
1 |
| 30 |
10424768 | Sequence-dependent antagonism between fluorouracil and paclitaxel in human breast cancer cells. | 1999 Aug 1 |
1 |
| 31 |
9930367 | p53- and p21-independent apoptosis of squamous cell carcinoma cells induced by 5-fluorouracil and radiation. | 1998 Nov |
2 |